SEC Form D · filed February 20, 2018
Evelo Biosciences, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (33)
Duncan P. Mchale · Cambridge, MAExecDavid P. Perry · Cambridge, MADirectorDavid A. Berry, M.D., Ph.D · Cambridge, MADirectorJennifer P. Glennon · Cambridge, MAExecLord Ara P. Darzi · Cambridge, MADirectorMark P. Bodmer, Ph.D · Cambridge, MAExecWilliam P. Devaul · Cambridge, MAExecBalkrishan (Simba) A. Gill, Ph.D · Cambridge, MAExec · DirectorTheodose A. Melas-Kyriazi · Cambridge, MADirectorNoubar B. Afeyan, Ph.D · Cambridge, MADirectorDavid R. Epstein · Cambridge, MADirectorRonan Guilfoyle · New Albany, OHDirectorAalok W. Shah · Houston, TXExec · DirectorDavid B. Kool · Los Angeles, CAExecTony S. Kim · Los Angeles, CADirectorDerrick W. Hale · Houston, TXExecJeffrey W. Harder · Houston, TXDirectorDharmesh P. Singh · Redmond, WADirectorMarc W. Duncan · Houston, TXExecTed P. Wang · Redmond, WADirectorGeoff Ruddick · New Albany, OHDirectorBrian Waterhouse · New Albany, OHExecMayTech Partners LLC · New York, NYDirectorHassan Mahmoud · Secaucus, NJExec · DirectorAbed Elsamna · Secaucus, NJExecMayTech Capital Management LLC · New York, NYExecBenjamin Bixby · Watertown, MADirectorJesse Sielaff · Watertown, MADirectorChris W. Jarrous · OAKLAND, CAExecCarter W. Dunlap · OAKLAND, CADirectorF. Jonathan N. Dracos · NEW YORK, NYDirectorJ. Michael N. O'Brien · NEW YORK, NYExecBrian T. Kelley · NEW YORK, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗